Hequan Li
- Topics
- Asthma and respiratory diseases (10 papers)IL-33, ST2, and ILC Pathways (4 papers)Immune Response and Inflammation (3 papers)
- Cited by
- ImmunologyOncologyPhysiology
In The Last Decade
Hequan Li
16 papers receiving 998 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Immunology 705
- Oncology 305
- Molecular Biology 183
- Physiology 183
- Pulmonary and Respiratory Medicine 136
Countries citing papers authored by Hequan Li
This map shows the geographic impact of Hequan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hequan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hequan Li more than expected).
Fields of papers citing papers by Hequan Li
This network shows the impact of papers produced by Hequan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hequan Li. The network helps show where Hequan Li may publish in the future.
Co-authorship network of co-authors of Hequan Li
This figure shows the co-authorship network connecting the top 25 collaborators of Hequan Li. A scholar is included among the top collaborators of Hequan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hequan Li. Hequan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 54 | |
| 3 | 12 | |
| 4 | 23 | |
| 5 | 23 | |
| 6 | Mannose prevents acute lung injury through mannose receptor pathway and contributes to regulate PPARγ and TGF-β1 level. | 13 |
| 7 | 13 | |
| 8 | 23 | |
| 9 | 5 | |
| 10 | 63 | |
| 11 | 59 | |
| 12 | 5 | |
| 13 | 65 | |
| 14 | Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-β1breakdown → | 639 |
| 15 | 3 | |
| 16 | 1 |
About Hequan Li
Hequan Li is a scholar working on Physiology, Immunology and Pharmacology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (10 papers), IL-33, ST2, and ILC Pathways (4 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Immunology (705 citations), Oncology (305 citations) and Physiology (183 citations). Hequan Li has collaborated with scholars based in China, Croatia and France. Frequent co-authors include Yanmei Han, Minggang Zhang, Xuetao Cao, Jianying Zhou, Dajing Xia, Qīng Wáng, Guohua Lu, Dajing Xia, Yinan Yao and Wanjun Yu. Their work appears in journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.